Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2026 19:26 ET | Source: Robbins LLP

TCOM Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Trip.com Group Limited Securities Class Action

Robbins LLP is Investigating Allegations that Trip.com Group Limited (TCOM) Understated the Risk of Regulatory Enforcement in light of its Monopoly
March 17, 2026 19:09 ET | Source: Robbins LLP

Robbins LLP Urges APO Stockholders Who Lost Money Investing in Apollo Global Management, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Apollo Global Management, Inc. (APO) Failed to Disclose to Investors that Jeffrey Epstein was Involved
March 12, 2026 17:54 ET | Source: Robbins LLP

TCOM Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Fraud Class Action Against Trip.com Group Limited

Robbins LLP is Investigating Allegations that Trip.com Group Limited (TCOM) Understated the Risk of Regulatory Enforcement in Light of its Monopoly
March 11, 2026 19:10 ET | Source: Robbins LLP

Driven Brands Holdings Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the DRVN Class Action

Robbins LLP is Investigating Allegations that Driven Brands Holdings Inc. (DRVN) Made Material Errors in its Previously Issued Consolidated Financial State
March 04, 2026 14:22 ET | Source: Robbins LLP

Robbins LLP Urges PMI Stockholders to Contact the Firm for Information About the Class Action Against Picard Medical, Inc.

Robbins LLP is Investigating Allegations that Picard Medical, Inc. (PMI) was the Subject of a Fraudulent Stock Promotion Scheme
March 04, 2026 13:40 ET | Source: Robbins LLP

Robbins LLP Urges MREO Stockholders to Contact the Firm for Information About the Class Action Against Mereo BioPharma Group plc

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
March 02, 2026 20:08 ET | Source: Robbins LLP

Robbins LLP Reminds CRWV Stockholders of the March 13, 2026 Lead Plaintiff Deadline – Contact the Firm Today for Information About Leading the CoreWeave, Inc. Class Action

Robbins LLP is Investigating Allegations that CoreWeave, Inc. (CRWV) Misled Investors Regarding its Ability to Accommodate Customer Demand
February 27, 2026 08:30 ET | Source: Robbins LLP

SNOW Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Filed Against Snowflake Inc.

Robbins LLP is Investigating Allegations that Snowflake Inc. (SNOW) Misled Investors Regarding its Business Prospects
February 26, 2026 09:00 ET | Source: Robbins LLP

CORT Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Corcept Therapeutics Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Corcept Therapeutics Incorporated (CORT) Misled Investors Regarding the Viability of its New Product.
February 20, 2026 17:00 ET | Source: Robbins LLP

PYPL Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against PayPal Holdings, Inc.

Robbins LLP is Investigating Allegations that PayPal Holdings, Inc. (PYPL) Misled Investors Regarding its Branded Checkout Offerings